Wyeth Sues Apotex Over Injectable Protonix ANDA
The generics producer is jumping the gun by filing an abbreviated new drug application with the U.S. Food and Drug Administration for a generic version of the drug before the patent has expired, Wyeth claims.
Wyeth, which distributes Protonix in the U.S., and German pharmaceutical company Nycomed GmbH, the owner of the patent in suit, filed the complaint Thursday in the U.S. District Court...
Already a subscriber? Click here to login